SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-028536
Filing Date
2024-02-08
Accepted
2024-02-08 17:35:57
Documents
1
Group Members
VERSANT VANTAGE II GP, L.P.VERSANT VANTAGE II GP-GP, LLCVERSANT VANTAGE II, L.P.VERSANT VENTURES VI GP, L.P.VERSANT VENTURES VI GP-GP, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d760791dsc13ga.htm SC 13G/A 104744
  Complete submission text file 0001193125-24-028536.txt   106566
Mailing Address ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 (415) 801-8100
Versant Venture Capital VI, L.P. (Filed by) CIK: 0001687880 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Subject) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92725 | Film No.: 24610378
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)